1. THERE ARE NO WARRANTIES, EXPRESSED OR IMPLIED, AS TO ACCURACY, COMPLETENESS, OR RESULTS OBTAINED FROM ANY INFORMATION DISCUSSED DURING HAWKTRADE MEETINGS. Past performance does not guarantee future results. Investment returns and principal value will fluctuate, so that investors' shares, when sold, may be worth more or less than their original cost. Investing in any financial instruments does not guarantee that an investor will make money, avoid losing capital, or indicate that the investment is risk-free. There are no absolute guarantees in investing. HAWKTRADE and its members do not bear any responsibility for losses or gains made by members trading on their personal accounts based on analysis from HAWKTRADE meetings.

3.  President  Vice-President  Director of Technology  Director of Marketing  Director of Group Simulations  Director of Finance  Director of Outside Events  Director of Research

4.  $15 to enter competition  All money goes to prizes so more people = better prizes  Call Options, Put Options, Short Selling  Top 8 get prizes (tentatively)  Director of Simulations will monitor for any irregularities

5.  Eleanor Miller – TIVO – (2.64%)

6. Helpful Resources

7.  CNBC  FOX Business  CNN Money  Bloomberg

8.  Twitter  Stock Twits (App)  Yahoo! Finance  Bloomberg

9.  IBIS World IBIS World  S&P Net Advantage S&P Net Advantage  Factiva Factiva  MarketLine Advantage MarketLine Advantage

10.  Bloomberg Calendar Bloomberg Calendar  Bureau of Economic Analysis Bureau of Economic Analysis  St. Louis FED (FRED) St. Louis FED (FRED)

11.  ThompsonOne Investment Banking ThompsonOne Investment Banking  Mergent Online Mergent Online  Morningstar Morningstar

12.  Bloomberg Surveillance  The Money Tree  The Investor’s Podcast  Taking Stock – Bloomberg

13.  Yahoo! Finance Screener Yahoo! Finance Screener  Finviz Finviz  CNBC Screener CNBC Screener  Zack’s Screener Zack’s Screener

16. Issued Patent for using Contrave for reducing cardiovascular risk Problem! Released ongoing trial data in patent MGMT told 100+ people and data leaked Stock Jumped 50% Short-term gains MGMT looking out for shareholders FDA + Trial Committee Angry at Orexigen Management Drug unlikely to decrease cardio risk Possible punishment? Increased FDA regulation on trial info?

18.  International trade balance narrowed to$- 41.8B from $-45.8B  Within consensus range  Exports fell 2.9% and imports dropped 3.9%  Will most likely lead to an upward GDP revision  Surpluses with:  South and Central America  Brazil  Deficits  China  European Union  Germany  OPEC  Canada  Japan

21.  AbbVie will buy all outstanding shares of Pharmacyclics for $261.25 a share  Stock holders will be can be compensated in AbbVie stock, cash or both Stock holders will be can be compensated in AbbVie stock, cash or both  Adds Imbruvica to an already robust research pipeline  Inhibitor useful in the detection of blood cancers  Has received three Breakthrough Therapy designations from the FDA

25.  All 31 banks included in the Federal Reserve test passed the DFAST stress test  The banks have enough capital to absorb losses during a prolonged and sharp economic slowdown  Goldman Sachs, J. P. Morgan, Morgan Stanley and Wells Fargo had lower common equity Tier 1 ratios  Precedes the tougher CCAR test, which assess the planned capital actions